Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00391547Phase 2Completed
Phase 2, open-label, single-arm trial of iodine in gingivitis, sponsored by Biomedical Development. Primary endpoint: Reduction of the Gingival Index values at 12 weeks. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00391547.